Such mechanisms might explain why some human tumors, including HB and HCC, often express high levels of wild-type p53 and occasionally co-express Bcl-2 and how p53 may at times actually facilitate tumor survival [36, 50–53]. Here, BCL2 is linked to hepatocellular carcinoma.